MANGOSTIN INHIBITS THE OXIDATIVE MODIFICATION OF HUMAN LOW-DENSITY-LIPOPROTEIN

被引:97
作者
WILLIAMS, P
ONGSAKUL, M
PROUDFOOT, J
CROFT, K
BEILIN, L
机构
[1] UNIV WESTERN AUSTRALIA,ROYAL PERTH HOSP,DEPT MED,PERTH,WA,AUSTRALIA
[2] PRINCE SONGKLA UNIV,FAC SCI,HAT YAI 90112,THAILAND
关键词
MANGOSTIN; LOW DENSITY LIPOPROTEIN; OXIDATION;
D O I
10.3109/10715769509064030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oxidation of low density lipoprotein (LDL) may play an important role in atherosclerosis. We investigated the possible antioxidant effects of mangostin, isolated from Garcinia mangostana, on metal ion dependent (Cu2+) and independent (aqueous peroxyl radicals) oxidation of human LDL. Mangostin prolonged the lagtime to both metal ion dependent and independent oxidation of LDL in a dose dependent manner over 5 to 50 mu M as monitored by the formation of conjugated dienes at 234nm (P < 0.001). There was no significant effect of mangostin on the rate at which conjugated dienes were formed in the uninhibited phase of oxidation. Levels of thiobarbituric reactive substances (TBARS) generated in LDL were measured 4 and 24 hours after oxidation with 5 mu M Cu2+ in the presence or absence of 50 mu M or 100 mu M mangostin. We observed an inhibition of TBARS formation with 100 mu M mangostin at 4 hours (P = 0.027) but not at 24 hours (P = 0.163). Similar results were observed in the presence of 50 mu M mangostin. Mangostin, at 100 mu M, retarded the relative electrophoretic mobility of LDL at both 4 and 24 hours after Cu2+ induced oxidation. Mangostin (100 mu M) significantly inhibited the consumption of a-tocopherol in the LDL during Cu2+ initiated oxidation over a 75 minute period (P < 0.001). From these results, we conclude that mangostin is acting as a free radical scavenger to protect the LDL from oxidative damage in this in vitro system.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 20 条
[1]   THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS [J].
BJORKHEM, I ;
HENRIKSSONFREYSCHUSS, A ;
BREUER, O ;
DICZFALUSY, U ;
BERGLUND, L ;
HENRIKSSON, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :15-22
[2]   LIPOPROTEIN METABOLISM IN THE MACROPHAGE - IMPLICATIONS FOR CHOLESTEROL DEPOSITION IN ATHEROSCLEROSIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :223-261
[3]  
CROFT KD, 1991, EICOSANOIDS, V4, P75
[4]   LOW-DENSITY-LIPOPROTEIN COMPOSITION AND OXIDIZABILITY IN CORONARY-DISEASE - APPARENT FAVORABLE EFFECT OF BETA-BLOCKERS [J].
CROFT, KD ;
DIMMITT, SB ;
MOULTON, C ;
BEILIN, LJ .
ATHEROSCLEROSIS, 1992, 97 (2-3) :123-130
[5]   EFFECT OF ANTIOXIDANTS ON OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
PUHL, H ;
DIEBERROTHENEDER, M ;
WAEG, G ;
RABL, H .
ANNALS OF MEDICINE, 1991, 23 (05) :573-581
[6]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[7]   INHIBITION OF OXIDATION OF HUMAN LOW-DENSITY-LIPOPROTEIN BY PHENOLIC SUBSTANCES IN RED WINE [J].
FRANKEL, EN ;
KANNER, J ;
GERMAN, JB ;
PARKS, E ;
KINSELLA, JE .
LANCET, 1993, 341 (8843) :454-457
[8]  
FREI B, 1993, J LIPID RES, V34, P2135
[9]   PHYSIOLOGICAL LEVELS OF ASCORBATE INHIBIT THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN [J].
JIALAL, I ;
VEGA, GL ;
GRUNDY, SM .
ATHEROSCLEROSIS, 1990, 82 (03) :185-191
[10]   PROBUCOL PREVENTS THE PROGRESSION OF ATHEROSCLEROSIS IN WATANABE HERITABLE HYPERLIPIDEMIC RABBIT, AN ANIMAL-MODEL FOR FAMILIAL HYPERCHOLESTEROLEMIA [J].
KITA, T ;
NAGANO, Y ;
YOKODE, M ;
ISHII, K ;
KUME, N ;
OOSHIMA, A ;
YOSHIDA, H ;
KAWAI, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5928-5931